Journal profile · PHARMACOLOGY & PHARMACY
Advances in Pharmacological and Pharmaceutical Sciences
ISSN 2633-4682 · eISSN 2633-4690 · John Wiley & Sons, Inc. · USA
Advances in Pharmacological and Pharmaceutical Sciences: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 1,000; median 196 days to acceptance (90 articles, last 24 months); 50 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Advances in Pharmacological and Pharmaceutical Sciences is published by John Wiley & Sons, Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Essential Oils and Antimicrobial Activity, Phytochemicals and Antioxidant Activities and Natural Antidiabetic Agents Studies, together about 25.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Advances in Pharmacological and Pharmaceutical Sciences is a peer-reviewed, Open Access journal that publishes original research articles, and review articles in all areas of experimental and clinical pharmacology, pharmaceutics, medicinal chemistry and drug delivery. Topics covered by the journal include, but are not limited to: Biochemical pharmacology, drug mechanism of action, pharmacodynamics, pharmacogenetics, pharmacokinetics, and toxicology. The design and preparation of new drugs, and their safety and efficacy in humans, including descriptions of drug dosage forms. All areas of medicinal chemistry, such as drug discovery, design and synthesis. Basic biology of drug and gene delivery through to application and development of these principles, through therapeutic delivery and targeting. Areas covered include bioavailability, controlled release, microcapsules, novel drug delivery systems, personalized drug delivery, and techniques for passing biological barriers.
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Kim Wei ChanPublisher website
Editorial board by country: 1 in mainland China (about 3%); most named India 6, Malaysia 4, Morocco 4, United States 2, Canada 2 (31 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences9.4%
- Phytochemicals and Antioxidant ActivitiesMedicine8.8%
- Natural Antidiabetic Agents StudiesMedicine7%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.8%
- Ethnobotanical and Medicinal Plants StudiesAgricultural and Biological Sciences5.8%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.2%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences5.2%
- Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCEmbaseCASCAB AbstractsPublisher website
Other: Google Scholar, EBSCO, ProQuest, CNKI, J-Gate
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 5.6LetPub ·
- SJR 2026-06
- 0.66LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 27OpenAlex ·
- i10-index
- 107OpenAlex ·
- 2-year mean citedness
- 3.46OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 48LetPub ·
Articles by year OpenAlex count · 343 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 41 | 1 |
| 2025 | 50 | 50 | 110 |
| 2024 | 87 | 87 | 505 |
| 2023 | 40 | 40 | 386 |
| 2022 | 49 | 49 | 897 |
| 2021 | 46 | 46 | 722 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
196 daysMedian, submission to acceptance · P25–P75 148 days – 302 days
- Acceptance to online
- median 27 days (90 articles)
- Submission to online
- median 223 days
- Sample
- 90 articles with submission and acceptance dates (87 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 17 weeksLetPub ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 1,000 / EUR 870 / GBP 740 | — | — | |
| LetPub | USD 925 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 300 words
- Reference style
- Chicago
- Suggested reviewers
- Optional
- Highlights
- Required
- Graphical abstract
- Optional
Article types accepted7
- original researchThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- research articleThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- research articlesResearch articles should present the results of an original research study. These manuscripts should describe how the research project was conducted and provide…Length not stated
- reviewThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- review articleThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- reviewsA review article provides an overview of the published literature in a particular subject area.Length not stated
- systematic reviewThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Peer review, Preprints, Trial registration / reporting guidelines
- Authorship Title and authorship information
The following information should be included: Manuscript title Full author names Full institutional mailing addresses Email addresses Affiliations. The publisher remains neutral with regard to jurisdictional claims in institutional affiliations. Responsibility for affiliations ultimately rests with the author, although the publisher may request changes be made to countries listed in affiliations t…
Source ↗Publisher website ·- Conflicts of interest Conflicts of interest
Concurrent submissions: max three manuscripts under review at any time. Model summary
Authors must declare all relevant interests that could be perceived as conflicting. Authors should explain why each interest may represent a conflict. If no conflicts exist, the authors should state this. Submitting authors are responsible for co-authors declaring their interests. Conflicts of interest (COIs, also known as 'competing interests') occur when issues outside research could be reasonab…
Source ↗Publisher website ·- Data availability Data availability
Data availability statement required with submission. Model summary
Authors must include a data availability statement with their submission. When submitting a manuscript, submitting authors will be asked to select from several pre-written statements or use the text editor to tell us about data availability with regard to their submission. Review our Data Sharing Policy to understand which data availability statement is right for your submission.
Source ↗Publisher website ·- License & copyright Copyright and permissions
Originality: not published, in press, or submitted elsewhere, except preprint servers. Model summary
Authors retain the copyright of their manuscripts, and all open access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not speci…
Source ↗Publisher website ·- Peer review Peer review
Peer review model: single-anonymized for applicable article types. Model summary
The journal follows a single-anonymized peer review model, for applicable article types. Information on the Peer Review model can be found here. Wiley's policy on the confidentiality of the review process is available here. All submitted articles are subject to assessment and peer review to ensure editorial appropriateness and technical correctness. Research published in the journal must be: Scien…
Source ↗Publisher website ·- Preprints Preprints
Preprints allowed and not considered a compromise of novelty. Model summary
The journal accepts articles previously published on preprint servers, and does not consider this to compromise the novelty of the results. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered. The preprint should be cited.
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting guidelines
Authors are strongly encouraged to use appropriate reporting guidelines when preparing and submitting manuscripts, to maximize transparency and reproducibility. Our editors and reviewers are also encouraged to use them in the review process. Completed checklists should be provided in the supplementary files on submission. We particularly encourage the use of: CONSORT for randomized controlled tria…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- John Wiley & Sons, Inc.
- Country or region
- USA
- Language
- English
- ISSN
- 2633-4682
- Electronic ISSN
- 2633-4690
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Advances in Pharmacological and Pharmaceutical Sciences
What CAS zone is Advances in Pharmacological and Pharmaceutical Sciences in?
In the 2025 upgraded edition of the CAS Journal Ranking, Advances in Pharmacological and Pharmaceutical Sciences is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Advances in Pharmacological and Pharmaceutical Sciences?
Based on the dates recorded on 90 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 196 days (interquartile range 148–302 days); authors report an average review time of about 17 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Advances in Pharmacological and Pharmaceutical Sciences?
According to the journal's author guidelines: Abstract: ≤ 300 words; Reference style: Chicago; Suggested reviewers: Optional; Highlights: Required; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Advances in Pharmacological and Pharmaceutical Sciences based?
Of the 31 board members whose country the journal's board page names, 1 (about 3%) are in mainland China; the countries named most often are India (6), Malaysia (4) and Morocco (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Advances in Pharmacological and Pharmaceutical Sciences?
According to LetPub and DOAJ records, Advances in Pharmacological and Pharmaceutical Sciences is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science, PMC, Embase, CAS and CAB Abstracts; that list has not been checked against each database.
Is Advances in Pharmacological and Pharmaceutical Sciences open access, and what is the APC?
Advances in Pharmacological and Pharmaceutical Sciences is a fully open-access journal. APC about USD 1,000.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .